Filing Details

Accession Number:
0001209191-17-021699
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-20 16:10:49
Reporting Period:
2017-03-16
Filing Date:
2017-03-20
Accepted Time:
2017-03-20 16:10:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236927 A Paul Friedman 1801 Augustine Cut-Off
Wilmington DE 19803
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-16 5,458 $18.32 302,976 No 4 M Direct
Common Stock Acquisiton 2017-03-16 2,849 $18.32 305,825 No 4 M Direct
Common Stock Disposition 2017-03-16 8,307 $151.45 297,518 No 4 S Direct
Common Stock Acquisiton 2017-03-17 41,693 $18.32 339,211 No 4 M Direct
Common Stock Disposition 2017-03-17 41,693 $148.18 297,518 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-16 5,458 $0.00 5,458 $18.32
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-16 2,849 $0.00 2,849 $18.32
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-17 41,693 $0.00 41,693 $18.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-02-08 No 4 M Direct
141,693 2020-02-08 No 4 M Direct
100,000 2020-02-08 No 4 M Direct
Footnotes
  1. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
  2. Represents weighted average sale price. Actual sale prices ranged from $151.09 - $151.75.
  3. Represents weighted average sale price. Actual sale prices ranged from $148.00 - $148.92.
  4. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.